1. Home
  2. PYXS vs SNCR Comparison

PYXS vs SNCR Comparison

Compare PYXS & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • SNCR
  • Stock Information
  • Founded
  • PYXS 2018
  • SNCR 2000
  • Country
  • PYXS United States
  • SNCR United States
  • Employees
  • PYXS N/A
  • SNCR N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • SNCR EDP Services
  • Sector
  • PYXS Health Care
  • SNCR Technology
  • Exchange
  • PYXS Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • PYXS 101.1M
  • SNCR 101.2M
  • IPO Year
  • PYXS 2021
  • SNCR 2006
  • Fundamental
  • Price
  • PYXS $1.50
  • SNCR $10.17
  • Analyst Decision
  • PYXS Strong Buy
  • SNCR Strong Buy
  • Analyst Count
  • PYXS 8
  • SNCR 1
  • Target Price
  • PYXS $9.43
  • SNCR $13.00
  • AVG Volume (30 Days)
  • PYXS 817.5K
  • SNCR 61.2K
  • Earning Date
  • PYXS 11-12-2024
  • SNCR 03-11-2025
  • Dividend Yield
  • PYXS N/A
  • SNCR N/A
  • EPS Growth
  • PYXS N/A
  • SNCR N/A
  • EPS
  • PYXS N/A
  • SNCR N/A
  • Revenue
  • PYXS $16,146,000.00
  • SNCR $170,789,000.00
  • Revenue This Year
  • PYXS N/A
  • SNCR $7.56
  • Revenue Next Year
  • PYXS N/A
  • SNCR $4.58
  • P/E Ratio
  • PYXS N/A
  • SNCR N/A
  • Revenue Growth
  • PYXS N/A
  • SNCR 61.81
  • 52 Week Low
  • PYXS $1.39
  • SNCR $5.40
  • 52 Week High
  • PYXS $6.85
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 36.16
  • SNCR 60.68
  • Support Level
  • PYXS $1.39
  • SNCR $8.52
  • Resistance Level
  • PYXS $1.82
  • SNCR $9.11
  • Average True Range (ATR)
  • PYXS 0.10
  • SNCR 0.55
  • MACD
  • PYXS 0.03
  • SNCR 0.11
  • Stochastic Oscillator
  • PYXS 25.58
  • SNCR 95.68

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: